25 Great Pulteney Street
About Medicximedicxi (MEH-DEE-CHEE) is a life sciences-focused investment firm, originally created at Index Ventures, a leading international venture capital firm with offices in London, San Francisco, Geneva, and St. Helier (Jersey).
Founder: Francesco De Rubertis, Kevin Johnson, Michele Ollier and David Grainger
Tweets by Medicxi
7 articles with Medicxi
The new financing will help the Boston-based biotech accelerate the development of its siRNA-based therapies for immuno-dermatology indications.
In a stunning fall from grace playing out this week, former Operation Warp Speed vaccine czar, Dr. Moncef Slaoui, issued a statement Thursday morning, as news emerged that he has resigned from additional biotech posts.
Moncef Slaoui Joins Medicxi
Diasome Pharmaceuticals Receives Funding Led By Medicxi
Medicxi Launches First $300 Million Late-Stage Life Sciences Fund Medicxi Growth 1 (MG1), Backed By Novartis Animal Health Inc. And Verily
Google's Verily and Novartis AG Jump Into Medicxi's $300 Million Life Science Investment Fund
Domain Therapeutics And Medicxi Launch Mavalon Therapeutics, Aimed At Halting The Progression Of Parkinson's Disease